Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.
about
Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospectsAccelerating policy decisions to adopt haemophilus influenzae type B vaccine: a global, multivariable analysisComparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence.Global challenges of implementing human papillomavirus vaccines.Using discrete choice modeling to evaluate the preferences and willingness to pay for leptospirosis vaccineMapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.Eurogin 2010 roadmap on cervical cancer prevention.Human papillomavirus: science and technologies for the elimination of cervical cancer.Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact.Does India need an indigenous HPV vaccine and why?Escherichia coli-derived virus-like particles in vaccine development.Social representations of human papillomavirus in Bogotá, Colombia.
P2860
Q26864711-BA0145AF-591A-4261-A629-703FC80FE608Q33543730-9991AC7E-C009-4B54-A5A8-7C038EDB5C96Q33934529-11CF9960-DF8C-4D41-881E-E736EB2F2817Q35121855-958B9A2F-B4DA-41D9-A8BA-ED125366CC70Q35128768-A9D18F83-2681-4003-A5B4-AC772493B244Q35887386-886F5D36-169E-438C-A885-1922C029F8E1Q35888255-1A9557A3-3986-46A2-BF60-B19CEB6E23BAQ37332709-67D96BDC-C101-4212-8760-11FC4DE45495Q37340445-159E847D-C0CF-4D53-990F-26719672AC09Q37773300-357A9AA5-2BC6-4E6C-A2B8-0B586B5A0C24Q37826158-A7EA61C4-C8FC-4F8F-8C1F-C75A0C0EED60Q37901056-4F3BF3A3-EADF-4BF5-9939-F00B3868612CQ37912228-66114344-21FE-497C-B232-F2ADB9C74A36Q44347265-34916680-B6D2-4594-B4B3-0396DC620A6DQ47132009-9EEE9E27-73C1-4741-91C5-679B978A3D41Q47230014-C08A1A50-A785-44C9-AB4D-A48D83C6A7C5
P2860
Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Introduction of human papillom ...... s for funding and procurement.
@en
type
label
Introduction of human papillom ...... s for funding and procurement.
@en
prefLabel
Introduction of human papillom ...... s for funding and procurement.
@en
P2093
P1433
P1476
Introduction of human papillom ...... s for funding and procurement.
@en
P2093
Jacqueline Sherris
John W Fitzsimmons
Jon Kim Andrus
M Teresa Aguado
Mark A Kane
P304
P356
10.1016/J.VACCINE.2008.05.003
P407
P478
26 Suppl 10
P577
2008-08-01T00:00:00Z